“…Recombinant LAB, heterologous producers of EntA, also show higher EntA production (1.5-to 18.5-fold) than E. faecium T136, and the EntA they produce shows higher antimicrobial activity (1.5-to 6.6-fold) than that of the EntA produced by E. faecium T136, although the specific antimicrobial activity of the EntA produced was lower than that deduced from its production (10,32). Recombinant LAB, heterologous producers of enterocin P (EntP) and hiracin JM79, also showed higher production and antimicrobial activity of both bacteriocins, whereas their specific antimicrobial activity differed from that of the enterocins produced by the natural enterococcal producers (9,22,36). It has been speculated that the lower specific antimicrobial activity of heterologous bacteriocins produced by LAB may be due to, among many other factors, deficiencies in disulfide bond (DSB) formation, a conserved mechanism for stabilizing extracytoplasmic proteins carried out by thiol-disulfide oxidoreductases (9,10).…”